CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Yamamoto, Hidekazu ^a   Masters, John R ^a   Dasgupta, Prokar ^b,c   Chandra, Ashish ^b   Popert, Rick ^b   Freeman, Alex ^d   Ahmed, Aamir ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; CD133 ANTIGEN; HERMES ANTIGEN;

ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER TISSUE; CELL SUBPOPULATION; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE TUMOR; SPHEROID CELL;

ANTIGENS, CD; ANTIGENS, CD44; BIOPSY; CELLS, CULTURED; EPITOPES; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6; MALE; NEOPLASTIC STEM CELLS; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867415876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046979     Document Type: Article

References (54)

1. Lawson DA, Witte ON, (2007) Stem cells in prostate cancer initiation and progression. J Clin Invest 117: 2044-2050.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
3. Isaacs JT, (2008) Prostate stem cells and benign prostatic hyperplasia. Prostate 68: 1025-1034.
4. Perez EA, Romond EH, Suman VJ, Jeong JH, Davidson NE, et al. (2011) Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31. Journal of Clinical Oncology 29: 3366-3373.
5. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, et al. (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105: 20882-20887.
6. Collins AT, Habib FK, Maitland NJ, Neal DE, (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114: 3865-3872.
7. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545.
8. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
9. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, et al. (2009) Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-8562.
10. Hadaschik BA, Gleave ME, (2007) Therapeutic options for hormone-refractory prostate cancer in 2007. Urologic Oncology-Seminars and Original Investigations 25: 413-419.
11. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON, (2007) Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A 104: 181-186.
12. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON, (2007) Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25: 2760-2769.
13. Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, et al. (2008) A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 14: 1384-1389.
14. Xin L, Lawson DA, Witte ON, (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A 102: 6942-6947.
15. Reynolds BA, Rietze RL, (2005) Neural stem cells and neurospheres-re-evaluating the relationship. Nat Methods 2: 333-336.
16. Ema H, Suda T, Miura Y, Nakauchi H, (1990) Colony formation of clone-sorted human hematopoietic progenitors. Blood 75: 1941-1946.
17. Reynolds BA, Weiss S, (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
18. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
19. Hudson DL, O'Hare M, Watt FM, Masters JR, (2000) Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 80: 1243-1250.
20. Uzgare AR, Xu Y, Isaacs JT, (2004) In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J Cell Biochem 91: 196-205.
21. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, et al. (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275: 5512-5520.
22. Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, et al. (1994) Differential Expression of Extracellular-Matrix Molecules and the Alpha(6)-Integrins in the Normal and Neoplastic Prostate. Am J Pathol 145: 167-174.
23. Hewett PW, Murray JC, (1993) Human Microvessel Endothelial-Cells- Isolation, Culture and Characterization. In Vitro Cell Dev Biol Anim 29A: 823-830.
24. van Beijnum JR, Rousch M, Castermans K, van der Linden E, Griffioen AW, (2008) Isolation of endothelial cells from fresh tissues. Nat Protoc 3: 1085-1091.
25. Bonkhoff H, Remberger K, (1993) Widespread Distribution of Nuclear Androgen Receptors in the Basal-Cell Layer of the Normal and Hyperplastic Human Prostate. Virchows Archiv A-Pathological Anatomy and Histopathology 422: 35-38.
26. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, et al. (2001) Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49: 271-278.
27. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, et al. (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A 107: 2610-2615.
28. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
29. Sato T, Vries RG, Snippert HJ, van de WM, Barker N, et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
30. Dorrell C, Erker L, Schug J, Kopp JL, Canaday PS, et al. (2011) Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 25: 1193-1203.
31. Rietze RL, Valcanis H, Brooker GF, Thomas T, Voss AK, et al. (2001) Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 412: 736-739.
32. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, et al. (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70: 491-501.
33. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
34. Hanahan D, Weinberg RA, (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674.
35. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, et al. (2001) Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49: 271-278.
36. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI, (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2: 162.
37. Qin J, Liu X, Laffin B, Chen X, Choy G, et al. (2012) The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10: 556-569.
38. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
39. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97: 14720-14725.
40. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
41. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, et al. (1997) Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci U S A 94: 10705-10710.
42. Whitford P, Mallon EA, George WD, Campbell AM, (1990) Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer 62: 971-975.
43. Griend DJV, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, et al. (2008) The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells. Cancer Res 68: 9703-9711.
44. Hermansen SK, Christensen KG, Jensen SS, Kristensen BW, (2011) Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. J Histochem Cytochem 59: 391-407.
45. Sotomayor P, Godoy A, Smith GJ, Huss WJ, (2009) Oct4A is Expressed by a Subpopulation of Prostate Neuroendocrine Cells. Prostate 69: 401-410.
46. Missol-Kolka E, Karbanova J, Janich P, Haase M, Fargeas CA, et al. (2011) Prominin-1 (CD133) Is Not Restricted to Stem Cells Located in the Basal Compartment of Murine and Human Prostate. Prostate 71: 254-267.
47. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR, (2006) Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7: 681-685.
48. de Wynter EA, Coutinho LH, Pei X, Marsh JC, Hows J, et al. (1995) Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 13: 524-532.
49. Liu AY, (2000) Differential expression of cell surface molecules in prostate cancer cells. Cancer Res 60: 3429-3434.
50. Liu AY, (1994) Expression of CD44 in prostate cancer cells. Cancer Lett 76: 63-69.
51. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, et al. (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
52. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933.
53. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, et al. (2008) Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 15: 638-648.
54. Ahmed N, Riley C, Rice G, Quinn M, (2005) Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clinical & experimental metastasis 22: 391-402.